AAB-001 (Bapineuzumab) Open-Label, Long-Term Extension Study in Patients With Mild to Moderate Alzheimer's Disease
Clinical trial NCT00606476 · TERMINATED
Trial details
- NCT number
- NCT00606476
- Sponsor
- JANSSEN Alzheimer Immunotherapy Research & Development, LLC
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2006-12-01
- Primary completion
- 2012-09-01
- Enrollment
- 194
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.